IL6 and metabolic dysfunction-associated steatotic liver disease: Recently, a multicenter retrospective study by Gao et al. showed that serum IL-6 levels were significantly higher in NAFLD patients after infection with SARS-CoV-2 than in non-NAFLD patients.